J&T Ventures and Lead Ventures have invested €6 million in health tech scale-up Xund to enhance digital healthcare interactions and insights.
Target Company Overview
Xund is an innovative health tech company specializing in digital solutions that enable healthcare providers to enhance their interactions with patients. The company focuses on transforming data into actionable insights, thereby improving efficiency and patient care. With a firm commitment to leveraging technology for better healthcare outcomes, Xund aims to streamline healthcare processes and contribute significantly to the evolving medical landscape.
Founded with the intent to bridge the gap between healthcare and technology, Xund has rapidly established itself as a critical player in this sector, offering a range of solutions designed to simplify healthcare management.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Czech Republic
The healthcare industry in the Czech Republic is undergoing significant transformation, driven by digitalization and technological advancements. As the country strives to modernize its healthcare system, there is a strong emphas
Similar Deals
Avadel Pharmaceuticals plc → XWPharma Ltd.
2025
Innovate Capital → EMSCO Scientific Enterprise, Inc.
2024
J&T Ventures and Lead Ventures
invested in
Xund
in 2024
in a Other VC deal
Disclosed details
Transaction Size: $6M